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Scholarly Project Introduction
Hypertension is a chronic disease that has been a major problem in the African American
community for decades. Although numerous research studies have examined interventions to
combat this disease, there has been very little research published that focused on African
Americans with hypertension in a rural setting. Rural residents experience many difficulties in
accessing healthcare services. This difficult access is a disadvantage that results in higher
morbidity and mortality rates compared to those of their urban counterparts. Being from a small
town in Mississippi, I have witnessed first hand the many barriers that are encountered.
Individuals who live in a rural community may have limited access to healthcare providers.
Residents may need to travel greater distances for healthcare, and the healthcare facilities in
these areas are small and oftentimes provide services only during particular hours. The main
objective of this DNP scholarly project was to evaluate a strategy to motivate African Americans
in rural communities to improve hypertension control as one step toward improved involvement
in their personal health.
This journey began with a synthesis of literature, which focused on reviewing the barriers
associated with medication non-adherence and interventions used to improve blood pressure
control. Once the information was gathered and the gaps were identified, the direction of the
scholarly project was clear. After clarifying the purpose of the project, work began to select a
theoretical framework for the project. The second paper describes the Integrative Model of
Behavior Change and the three-step process used to motivate and encourage behavior change.
With the purpose clearly defined and a strong theoretical foundation, the scholarly project was
planned, implemented, evaluated, and disseminated. The final paper describes that process.
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The work reflected in these papers is a beginning with the potential to positively impact
the health of African Americans with hypertension in a small rural community. Perhaps the
beginning work will spread beyond this single community. The author is encouraged about the
potential of this work to continue positive influence on health.
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Barriers to Medication Adherence and Interventions Used to Create
Success in Hypertension: A Synthesis of Literature
Laneita Davis, FNP-BC, DNP-candidate
Belmont University
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Abstract

Background: Rates of medication adherence are low among hypertensive blacks despite
numerous interventions to increase their adherence. Purpose: The aim of this paper was to
conduct a review of literature to identify the published barriers to medication adherence in
African-American patients with hypertension and to review the published interventions and
strategies used to create success. Methods: A systematic computer search of qualitative and
quantitative studies was performed that examined factors associated with medication adherence
and interventions used in hypertensive African Americans from 2001 to 2013. Studies were
included if medication adherence was either the primary or secondary outcome variable. Results:
Selected studies (n = 27). Conclusion: Barriers to medication adherence included patient,
therapy, and provider related barriers. Interventions that were associated with medication
adherence included three main categories: pharmacy based, nurse led, and patient related.
Keywords: hypertension, medication adherence, African Americans, interventions
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One in four adults has hypertension (HTN), which highlights the prevalence of HTN as a
wide spread problem (Fernandez, et al., 2011). African Americans have a higher prevalence and
greater severity of HTN than do other minorities and Caucasians. The prevalence of HTN in
African Americans is among the highest in the world. HTN develops earlier in life and average
blood pressures (BPs) are much higher in African Americans than in Caucasians. African
Americans also have higher rates of stage-3 HTN, causing a greater burden of HTN
complications (Artinian, Washington, & Templin, 2001). Although scientific evidence has
established an array of both non-pharmacologic and pharmacologic strategies that reduce BP, the
rate of awareness, treatment, and control of HTN in the US population is declining, increasing
danger for African American in particular (Frinkelstein & Cha, 2009). Non-adherence to
prescribed medications threatens the health and well-being of patients and has costly financial
implications. Medication non-adherence causes the death of nearly 125,000 Americans every
year and has been linked to an estimated 10% of hospital and 23% of nursing-home admissions
(Migneault, Dedier, Wright, Heeren, Campbell, Morisky, Rudd, & Friedman, 2012).
According to a 2003 report by the World Health Organization (WHO), medication
adherence is the extent to which a person’s behavior in taking medications corresponds with the
agreed communication of their health care provider (Brown & Bussell, 2011). Therefore,
medication adherence is one of the most important factors in keeping the vital link between the
treatment and the therapeutic outcomes in medical care. To achieve better BP control in African
Americans, optimal medication adherence must be achieved. Unfortunately, medication nonadherence rates are high among African Americans, and there is indication that non-adherence
rates for African American are worse when compared with Caucasians (Artinian et al., 2001).
Non-adherence has been associated with misunderstanding of the condition, perceived
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improvement in health, worsening in health, general disapproval of medications, and concern
over side effects (Nair, et al., 2011). Many of the instances of patients not taking medicines to
minimize side effects are pragmatic. For the majority of patients who have no symptoms with
hypertension, the fact that they do not feel unwell may encourage non-adherence. Side effects
may be unacceptable in a condition that is asymptomatic. The number of medicines prescribed
may also influence adherence, with a reduction in compliance as the regime becomes more
complex (Artinian et al., 2001). The aim of this paper was to conduct a review to identify

published barriers to medication adherence in African-American patients with hypertension and
to review the published interventions and strategies used to create success.
Methods
The MEDLINE, CINAHL (Cumulative Index to Nursing and Allied Health), and Academic
Search Premier databases literature search was limited to English articles published between
2003 and 2013 using the following terms: medication adherence, interventions, hypertension and
African Americans. Additional references were obtained from citations within the retrieved
articles. Qualitative or quantitative studies that identified barriers to medication adherence in
African Americans and the interventions used to create success were the major focus of this
literature review. Studies that examined racial disparities in medication adherence and reported
on factors associated with adherence in African Americans were included in this literature
review. Inclusion criteria were: 1) African Americans with hypertension, 2) prescribed
medication treatment for high blood pressure, and 3) peer-reviewed articles. The majority of
articles screened and excluded were quantitative studies that did not measure medication
adherence as a study outcome.
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Results
A total of 56 citations from the databases were identified. After screening the abstracts for

their relevance and eliminating duplicate records, 22 articles were reviewed. Another five articles
were added after reviewing the references of the selected literature. The final number of articles
included in this review was 27. Ten (10 of 27, 37%) examined patient related barriers to
medication adherence (Table 1). Four studies (4 of 27, 15%) examined therapy related barriers
(Table 2), and four studies (4 of 27, 15%) examined provider related barriers to medication
adherence (Table 3). There were seven studies (7 of 27, 30%) that examined interventions used
to increase medication adherence. Three (3 of 7, 43%) examined patient related interventions
(Table 4). Two (2 of 7, 30%) examined nurse-based interventions (Table 5), and two (2 of 7,
30%) examined pharmacy related interventions (Table 6). Some studies fit in multiple sections.
Patient-related Barriers
Gender
According to Courtenay, McCreary, and Merighi (2002), men are less likely than women to
engage in a variety of preventive and self-care techniques, and the failure to do so contributes to
men’s increased health risks. Not only are men less likely than women to restrict their activities
or stay in bed when they are suffering from acute or chronic conditions, but also they are less
likely to persist in caring for a major health problem (Courtenay et al., 2002) In their crosssectional study, Shea and colleagues (2002) found that men were more likely to be nonadherent
to their antihypertensive medications than were women, and that women are more likely than
men to engage in a variety of health- promoting behaviors and healthier life- style patterns. Four
additional articles found no association between gender and medication adherence (Lague, et al.,
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2009; Lukoscheck, 2003; Krousel-Woods, Muntner, and Joyce, 2010; Turner, Hollenbeak,
Weiner, Ten Have, & Roberts, 2009). See Table 1.
Knowledge
It is arguably, surprising to discover that patients with a chronic condition, such as
hypertension, lack basic knowledge about its potential risks and medication’s positive role even
in the absence of symptoms. The patient’s knowledge and awareness of hypertension was
significantly associated with compliance to medication for hypertension (Al-Meza, Al-Muhailije,
Khalfah, & AL-Yahya, 2009). This correlation highlights the importance of health education to
increase the knowledge of hypertension in order to improve the patient’s compliant behavior.
Patel and Taylor (2002) report that patients who knew the importance of compliance had a
significantly higher compliance rate than those who were ignorant of that aspect. Findings from
the qualitative studies reported themes that described patients who believed that the absence of
HTN symptoms influenced them to become nonadherent (Ferdinand, 2009; Gascon, SanchezOrtuno, Llor, Skidmore, & Saturno, 2004; Lukoschek, 2003). In a cross-sectional study
examining comorbidities and medication adherence in blacks, Lague and colleagues (2009)
found that those patients having stage 2 HTN (either systolic BP >159 mm Hg or diastolic BP
>99 mm Hg) were more likely to have better adherence. Stage 2 hypertension is severe and
requires immediate medical attention. Without medication, serious complications can occur such
as blood vessel rupture, swelling of the brain and kidney failure (Lague et al., 2009). If the
patient were to experience any symptoms at this stage, they may encounter dizzy spells, blurry
vision (visual disturbance), headache or nausea. See Table 1.
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Therapy-related Barriers

Therapy-related factors include the complexity of the medical regimen, duration of treatment,
frequent changes in treatment, and adverse effects (Fongwa, Evangelisa, Hays, Martins,
Elaghoff, Cowan & Morisky, 2008). Studies examining therapy-related factors to medication
adherence among hypertensive African Americans have been primarily qualitative. In these
qualitative studies, patients have described medication adverse side effects as causing adjustment
to antihypertensive medication dosages including discontinuation (Gascon et al., 2004). Complex
treatment is believed to threaten the patient’s compliance. However, compliance does not seem
to correlate with the number of drugs prescribed, but the number of dosing times every day of all
prescribed medication (Ren, Kazis, Lee, Zhang, & Miller, 2002). Medications with once-daily
dosing may be preferable to medications with multiple doses per day because minimizing the
frequency of dosing has been shown to improve adherence (Schroeder, Fahey, & Ebram, 2004).
See Table 2.
Provider-related Barriers
Healthcare providers play an integral role in medication adherence. Patients who trust their
physicians have better two-way communication with their physician. Trust and communication
are two elements critical in optimizing adherence. . Numerous studies show that provider trust is
more important than treatment satisfaction in predicting adherence to prescribed therapy and
overall satisfaction with care (Piette, Heisler, Krein, & Kerr, 2005). Physician trust correlates
positively with acceptance of new medications, intention to follow physician instructions,
perceived effectiveness of care, and improvements in self-reported health status (Piette, et al.,
2005). Haskard and DiMatteo (2009) found that there is a 19% higher risk of non-adherence
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among patients whose physician communicates poorly than among patients whose physician
communicates well. Statistically, the odds of patient adherence are 2.26 times higher if a
physician communicates well (Haskard & DiMatteo 2009). A qualitative study by Lukoshek
(2003) found that patients describing their beliefs that quality of communication with their
healthcare providers was an important influence on their medication adherence. Quantitative
studies supported qualitative findings and have reported that patients with healthcare providers

who are empathetic, nonjudgmental, and collaborative are significantly more likely to adhere to
their medications (Odedosu, Schoenthaler, Vieira, Agyemang, & Ogedegbe, 2012). See Table 3.
Interventions
Patient-based Interventions
The most common approaches to improving blood pressure control at the patient level
regardless of race is patient education to address misconceptions about hypertension and to
improve adherence to drug therapy (Odedosu et al., 2012). In trying to overcome patient-related
barriers, emphasis should be on patient education, in particular addressing misconceptions about
hypertension and promoting adherence to antihypertensive therapy. According to Odedosu et al.,
(2012), patient education can improve blood pressure and its aims are to increase patients’
understanding of the disease and to encourage them to be more active in their own care.
Computer interventions have emerged as an effective approach to increasing health
knowledge, health- related skills, and health outcomes (Odedosu et al., 2012). Migneault et al.,
(2012) evaluated a culturally adapted, automated telephone system to help hypertensive, urban
African– American adults improve their adherence to their antihypertensive medication regimen
and to evidence-based guidelines for dietary behavior and physical activity. The totally
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automated, computer-based, interactive telephone counseling system, called Telephone-LinkedCare, monitored, educated, and counseled African–American adults with hypertension and
provided summary data regularly to the patient’s primary care provider (Migneault et al., 2012).
The automated service was associated with improvements in overall diet quality and energy
expenditure. A decrease in systolic BP between groups was not statistically significant (−2.3
mmHg, p = 0.25). Although the treatment group’s adjusted 7-item Morisky Medication
Adherence Scale scores improved by 0.19 points relative to controls, this change was not
statistically significant (p = 0.25) (Migneault et al., 2012).
Motivational interviewing is a promising patient-centered approach for improving
adherence in patients with chronic disease. Motivational interviewing is defined as a directive,
patient-centered approach to counseling designed to motivate people for change by helping them
to recognize and resolve the discrepancy between their present behavior, and their future
personal goals and values (Obedegbe, Chaplin, Schoenthaler, et al., 2008). Motivational
interviewing is composed of principles and techniques drawn from various theoretical
paradigms, the most important of which are its patient-centeredness, its ability to enhance
patient's self-efficacy, and its focus on patients' readiness to change behavior. Ogedegbe et al.,
(2008) randomized 190 hypertensive African American patients to receive usual care or quarterly
counseling sessions that used motivational interviewing focused on medication adherence. The
counseled patients stayed adherent to their medications, whereas adherence declined
significantly in those receiving usual care. This effect was associated with a modest, nonsignificant trend toward a net reduction in systolic blood pressure with motivational
interviewing. See Table 4.
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Nurse-based Interventions
Bosworth, Olsen, Grubber, et al., (2009) study of a practice in which almost half the
patients were African American, randomized patients to receive usual care, nurse-administered
tailored behavioral telephone counseling, home blood pressure monitoring, or home monitoring
plus tailored behavioral telephone counseling. Bosworth et al., (2009) found that a combination
of home monitoring and tailored behavioral telephone counseling led to a statistically significant
improvement in blood pressure control at 24 months compared with baseline. Artinian et al.,
(2001) evaluated the effect of nurse-managed telemonitoring on blood pressure control vs.
enhanced usual care. The monitored group had a significantly greater reduction in systolic
pressure at 12 months compared with those who received enhanced usual care. See Table 5.
Pharmacy-based Interventions
Pharmaceutical interventions have been shown to improve the BP control in hypertensive
patients by increasing the appropriateness of prescribing and adherence to treatment. Ramanath,
Nagakishore, & Kumar, (2012) study showed that clinical pharmacist intervention among a rural
population has a very strong positive impact in creating awareness about the disease, and its
maintenance by increasing their medication adherence. Hunt, Siemienczuk, Pape, et al., (2008)
conducted a randomized controlled trial in which pharmacists actively participated in the
management of blood pressure. The pharmacists reviewed medications and adverse drug
reactions, assessed lifestyle behaviors and barriers to adherence, made dosing adjustments, and
added medications. Patients randomized to the intervention group achieved significantly lower
systolic and diastolic pressures (137/75 vs. 143/78 mm Hg in the control group). However,
information about race was not included. See Table 6.
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Conclusion

The purpose of this paper was to determine the factors associated with medication adherence
in hypertensive African Americans and successful interventions. Barriers associated with nonadherence included patient, physician, and therapy related barriers. Medication adherence is
primarily in the domain of the patient. Because patients recall as little as 50% of what is
discussed during the typical medical encounter, effective patient education must be
multifactorial, individualized, and delivered in a variety of methods and settings outside of the
examining room (WHO, 2003). A key component of any adherence-improving plan is patient
education.
The substantially improved adherence of patients who report a good relationship with
their physician highlights the important role of physicians in the medication adherence equation.
Similar to any relationship, one key to a good physician-patient relationship is effective
communication. Thus, perhaps the foremost strategy providers can use to increase medication
adherence is to follow a patient-centered approach to care that promotes active patient
involvement in the chronic disease management decision–making process.
Addressing therapy-related factors should contribute positively in improving patient
compliance. Prescribing medication with non-invasive route of administration (eg, oral
medication) and simple dosing regimens might motivate patients to be compliant. Long duration
of treatment period and medication side effects might compromise patient’s beliefs about
medication effectiveness (Jin, Sklar, On, & Li, 2008). Therefore, healthcare providers should
consider therapy-related problems when designing the therapy plan and involve the patients in
the process to minimize the possible therapeutic barriers.
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Although there is a growing body of literature on interventions to reduce disparities in
hypertension and blood pressure control between African Americans and Caucasians, gaps in the
literature still exists. Only a few randomized controlled trials have focused on African
Americans. The majority of articles used in this review are not considered recent (within past 5
years), and this may be related to a number of factors. First, there may be a professional
disinterest in hypertension in the African American community. Hypertension in this population
has been an ongoing problem for decades and researchers may have turned their attention to
other pressing issues that are affecting the population as a whole. Secondly, because changing
ones behavior is challenging, researchers may be reluctant to tackle such a recalcitrant task.
However, the work must continue in order to positively impact the health of hypertensive
African Americans. While interventions for improving medication adherence have successfully
enhanced adherence in the short-term, the findings for longer-term chronic disease medication
are discouraging. Furthermore, the majority of interventions designed to improve adherence have
been conducted in urban settings, and thus, little is known of their effectiveness in rural areas.
More research is needed to better understand the optimal combination of interventions and user
characteristics to improve medication adherence among hypertensive African Americans in a
rural setting.
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Table 1: Patient-related barriers to medication adherence
Author and Journal

Sample

Methods

Findings

Al-Mehza, A, Al-Muhailije,
F. (2009). European
Journal of General
Medicine 6(1), 6-10

There were 154 hypertensive
patients from a hypertension
clinic in Kuwait were
followed for 6 months

Non-compliance was a significant
predictor for uncontrolled
hypertension. Knowledge and
awareness of HTN was significantly
associated with compliance. More than
half of the non-compliant patients
reported forgetfulness and absence of
symptoms of HTN as reasons for their
non-compliance.

Courtenay, W., McCreary,
R. & Merighi, J. (2002).
Journal of Health
Psychology, 7(3), 219-231

A convenience sample of
1816 undergraduate students,
ranging in age from 18 to 72
years (M = 22 years, SD = 6
years), was recruited from
three four-year, Englishlanguage, California public
universities. The sample was
comprised of 60 percent
women. Thirty-seven percent
of the sample was Asian
American, 28 percent
European American, 18

Three BP measures were in
an interval of at least 4 weeks
after being on meds for at
least 3 months. Participants
were labeled un-controlled
hypertensive if the mean of
the three measures of SBP
≥140mmHG and/or DBP was
≥90mmHG. Self-report and
pill count measured
participant’s non-compliance.
Subjects who had consumed
less than 80% of the
prescribed drugs were labeled
as being non-compliant.
To assess health risk
behaviors, a series of seven
behavioral and three
attitudinal/belief domains
were identified. A list of
behaviors or beliefs was then
generated for each domain. A
total of 48 items were
produced in all. The seven
behavioral domains were:
diet, exercise and fitness,
substance use, preventive
care, social support, safety,

Men were more likely than women to
engage in behaviors and adopt beliefs
that were detrimental to their health. A
secondary finding was that many of the
health risk behaviors examined were
intercorrelated. For example, Diet was
positively correlated with Anger and
Stress, Preventive Care, Medical
Compliance and Substance Use; the
Anger and Stress domain was also
correlated with both Preventive Care
and Substance Use.
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percent Hispanic, 6 percent
African American and 12
percent reported their
ethnicity as Other (e.g.
Middle Eastern) or Mixed
Heritage

and anger and stress.

Ferdinand, K. (2009).
Cardiology Review, 26(1),
17-19

NA

NA

Gascon, J., Sanchez-Ortuno,
M., Skidmore, L., &
Saturno, J. Family Practice,
21(2), 125-130

Non-compliant hypertensive
patients diagnosed with and
receiving treatment for
hypertension. Inclusion
criteria were anyone ages of
18-80yrs, being treated with
anti-hypertensive for
>3months, being noncompliant and having
sufficiently good physical
and mental health.
2180 black and white adults
aged 65 and older and
prescribed antihypertensive
medication.

A qualitative study with
seven focus groups
discussions conducted in
March-May 2001. Patients
were identified as noncompliant, using the
Morisky-Green test at two
primary health care centers of
the Spanish National Health
Services.

Krousel-Wood, M.,
Muntner P, Joyce, C. et al.
(2010). Journal of
American Geriatrics
Society, (58)1, 54-61.

A cross sectional design.
Information on CAM use
(health food and herbal
supplements, relaxation
techniques) for blood

Adherence to antihypertensive
medication regimens is difficult,
especially in African Americans. Lack
of adherence to blood pressure
medications predicts poor control and
is one of the underlying factors for the
serious health disparities regarding
morbidity and morality observed in
African Americans.
A complex web of factors influenced
non-compliance including fears and
negative images of anti-hypertensive
drugs and lack of basic background
knowledge about hypertension. The
clinical encounter was unsatisfactory
because of length, few explanations
given by the physician and low
physician-patient interaction
In this cohort of older managed care
patients, CAM use was associated with
low adherence to antihypertensive
medication in blacks but not whites.
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pressure control and
antihypertensive medication
adherence were collected in a
telephone survey between
August 2006 and September
2007. Low medication
adherence was defined as a
score less than 6 using the
eight-item Morisky
Medication Adherence Scale.
Lague,T., Weiner, M.,
Eachus, S., Tang, S.,
Schwartz, J., & Turner, B.
(2009). American Journal
of Managed Care, 15(1),
24-30

327 African Americans aged
>or=18 years

Cross-sectional study of
patients enrolled in a
Medicaid managed care plan
and treated in 6 primary care
practices. Prescription filling
was defined as a match
between a new or renewed
electronic prescription and an
insurance claim within the 30
days. The study assessed the
association of comorbidity
type with filling an
antihypertensive prescription
by using an adjusted logistic
regression model that
accounted for clustering of
prescriptions within patients.

Lukoscheck,P. (2003).
Journal of Health Care for

Hypertensive African
Americans were recruited

A qualitative study to explore
hypertensive African

1. Age 50 years or younger was
associated with lower
adherence.
2. Having 5 or more noncardiovascular comorbidities
was associated with higher
adherence.
3. Cardiovascular comorbidities
were not associated with
adherence.
4. Having stage 2 hypertension
was significantly associated
with higher adherence.

Themes identified that adherence may
be influenced by: 1. Adaptation and
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the Poor and Underserved,
14(4), 566-587.

Patel, K., & Taylor, S.
(2002). Annals of
Pharmacotherapy, 36(1),
40-45

Shea, S., Misera, D.,
Ehrlich, M., Field, L., &
Francis, C. (2002).
American Journal of Public
Health, 82(12), 1607-1612.

from an urban, public
hospital and divided into two
categories: adherent, wellcontrolled versus nonadherent, poorly controlled
participants
Patients were recruited from
the University of Michigan
hypertensive clinic.
Inclusion: 1. >18 years 2.
Regular attendance at the
clinic 3. Diagnosis of
hypertension within 1 year
prior to completing the study,
and 4. A goal to reduce
hypertension. There were 102
participants with 46 males
and 56 females.
Subjects (n = 202) were
interviewed as part of a casecontrol study of severe,
uncontrolled hypertension
conducted in two New York
City hospitals. All subjects
were African American or
Hispanic.

Turner B., Hollenbeak, C.,
300 hypertensive patients
Weiner, M., Ten Have T., & aged >70 from four urban
Roberts, C.(2009),
primary care practices.
Pharmacoepidemiology &

Americans beliefs and
attitudes regarding
hypertension that might serve
as barriers to hypertension.

preservation of health beliefs, 2.
Absence of disease symptoms. 3.
Distrust, stress, and perception of
racial prejudice, and 4. Patientprovider relationship.

A prospective, cross sectional
survey of hypertensive
patients assessed patients’
health beliefs, illness
attributions, and perceived
control. Six months later a
follow-up telephone survey
determined medication
adherence.

Patients indicated that modifiable
variables were the most common
attribution believed to cause
hypertension; however, there was no
significant relationship to medication
adherence.

Self-reported non-adherence
to drug treatment for
hypertension was measured
using a five-item scale, and
the sample was dichotomized
as more (n = 87) or less (n =
115) adherent. Multiple
logistic regression analysis
was used to adjust for
demographic and other
covariates.
Participant’s annual mean
systolic blood pressure was
calculated from electronic
records. Subjects were asked

Changing the locus of care for
hypertension from emergency rooms to
primary care physicians may improve
adherence to hypertension treatment in
minority populations.

Self-reported adherence was associated
with a higher blood pressure,
especially in elderly black patients. To
promote adherence data suggest
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Drug Safety, (18) 8, 672681

about the last missed
antihypertensive dose in six
time intervals. Based on
association with blood
pressure control, nonadherence was defined as
missing any dose in the past 3
months. Subjects were also
asked about six domains of
adherence barriers: health,
personal support, drug
coverage, medication filling
and use, doctor–patient
interaction and knowledge.
All models were adjusted for
demographics, treatment
regimen, and sampling
weights.

targeting the filling of prescriptions,
prioritizing hypertension care and
educating about effects of
hypertension.
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Table 2: Therapy-related barriers to medication adherence
Author & Journal
Fongwa, M., Evangelisa, L.,
Hays, R., (2008). Vascular
Health and Risk Management
4(1), 157-166

Sample
African American women
receiving treatment for the
disease from an ambulatory
inner-city free clinic in West
Los Angeles. Five focus group
interviews were conducted with
20 hypertensive African
American women, 35 years and
older.

Methods
Qualitative study in which
transcripts from the tapes were
analyzed for content describing
adherence to treatment factors.

Findings
Factors associated with
adherence to treatment included
beliefs about hypertension,
facilitators of adherence to
treatment, and barriers to
adherence to treatment.
Recommendations included
need for culturally sensitive
education on managing
hypertension and medication
side effects, early screening for
depression.

Gascon, J., Sanchez-Ortuno,
M., Skidmore, L., & Saturno, J.
Family Practice, 21(2), 125130

Non-compliant hypertensive
patients diagnosed with and
receiving treatment for
hypertension. Inclusion criteria
were anyone ages of 18-80yrs,
being treated with antihypertensive for >3monts,
being non-compliant and
having sufficiently good
physical and mental health.

A qualitative study with seven
focus groups discussions
conducted in March-May 2001.
Patients were identified as noncompliant, using the MoriskyGreen test at two primary
health care centers of the
Spanish National Health
Services.

A complex web of factors
influenced non-compliance
including fears and negative
images of anti-hypertensive
drugs also a lack of basic
background knowledge about
hypertension. The clinical
encounter was viewed as
unsatisfactory because of
length, few explanations given
by the physician and low
physician-patient interaction.

Ren, X., Kazis, L., Lee, A.,
Zhang, H., & Miller, D. (2002)
Journal of Clinical Pharmacy
and Therapeutics, 27(1), 47-56

Prescription records from
patients who were in the
Veterans Health Study (VHS).
2425 patients agreed to

Participants completed the
Veterans Short-Form Health
Survey, plus in person
interview. Within a month they

Number of medications was
positively associated with
compliance. Patient who were
more involved in treatment
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participate.

Schroeder, K., Fahey, T., &
Ebram, S. (2004). Archives of
Internal Medicine, 164(7), 722732.

completed a physical exam,
clinical assessment, and a
medical history. Patients’ selfreported medication
compliance included four
questions, originally developed
and validated by Morisky and
colleagues.
A systematic review of
randomized controlled trials. 38
studies testing 58 different
interventions and containing
data on 15,519 patients. The
studies were conducted in 9
countries between 1975 and
2000.

decisions were more compliant
than those who were less
involved in treatment decisions.
Physician’s age had a negative
effect on compliance.

Reducing the number of daily
doses appears to be effective in
increasing adherence to blood
pressure-lowering medication
and should be tried as a firstline strategy. Some
motivational strategies and
complex interventions appear
promising.
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Table 3: Provider-related barriers to medication adherence
Author and Journal
Haskard Zolnierek, K., &
DiMatteo, R. (2009). Medical
Care. 47(8), 826-834.

Sample
Database searched yielded 128
articles which focused on
adherence and communication

Method
Meta-analysis of 106
correlational studies and
21interventional studies
evaluating the effects of
physician communication
training on the outcome of
patient adherence.

Findings
Physician communication is
significantly positively
correlated with patient
adherence. Training physicians
in communication skills
resulted in improvements in
patient adherence. With
training the odds of patient
adherence are 1.62 times
higher.

Odedosu,T., Schoenthaler, A.,
Vieira, D., Agyemang, C., &
Ogedegbe, G. (2012) Cleveland
Clinic Journal of Medicine,
79(1), 46-56

A data search yielded articles
focused on barriers to
hypertension control in African
Americans and interventions
used to create success. No
number was reported for
articles used.

A systematic review focusing
on barriers to hypertension in
African Americans and
interventions used.

Barriers contributing to
patient’s non-compliance were
patient r/t (lack of knowledge,
inability to engage in lifestyle
modification, health beliefs, &
medication side effects),
physician-r/t (non-adherence to
treatment guidelines, failure to
emphasize lifestyle
modifications), health care
system r/t (lack of access to
care, high cost of medications).
Recommendations to overcome
theses barriers should focus on
patient education, self –
monitoring with a home blood
pressure monitor, behavioral
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Piette, J.D. Heisler, M., &
Krein, S., & Kerr, E. (2005).
Archives of Internal Medicine,
165(15): 1749-1755.

912 patients with diabetes
recruited from 5 Veterans
Affairs health systems.

A detailed cross-sectional
survey where patients reported
their level of physician trust.
Results were stratified into
high-trust (n = 557) and low
trust (n = 355).

Lukoscheck,P. (2003). Journal
of Health Care for the Poor
and Underserved, 14(4), 566587.

Hypertensive African
Americans were recruited from
an urban, public hospital and
divided into two categories:
adherent, well-controlled
versus non-adherent, poorly
controlled participants.

A qualitative study to explore
hypertensive African
Americans beliefs and attitudes
regarding hypertension that
might serve as barriers to
hypertension.

counseling, and physicianrelated interventions.
A trusting physician
relationship may moderate the
impact of cost pressures on
patients' medication adherence.
Addressing non-cost barriers to
adherence may reduce rates of
cost-related medication
underuse.
Themes influencing adherence
included: 1. Adaptation and
preservation of health beliefs,
2. Absence of disease
symptoms. 3. Distrust, stress,
and perception of racial
prejudice, and 4. Patientprovider relationship.
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Table 4: Patient- Related Interventions
Author and Journal
Odedosu,T., Schoenthaler, A.,
Vieira, D., Agyemang, C., &
Ogedegbe, G. (2012) Cleveland
Clinic Journal of Medicine,
79(1), 46-56

Sample
A data search yielded articles
on barriers to hypertension
control in African Americans
and interventions used to create
success. No number was given
for the amount of articles used.

Method
A systematic review focused on
barriers to hypertension in
African Americans and
interventions used.

Obedegbe, G. et al., (2008).
American Journal of
Hypertension, 21(10), 11371143.

190 hypertensive African
Americans (88% women; mean
age 54 years). Patients were
recruited from two communitybased primary care practices in
New York City.

Randomized controlled trial of
a practice-based MINT
counseling vs. usual care (UC)
on medication adherence and
blood pressure (BP). Outcomes
were adherence measured by
electronic pill monitors; the
secondary outcome was withinpatient change in office BP
from baseline to 12 months.

Findings
Barriers that contributed to
patient’s non-compliance, were
patient r/t (lack of knowledge,
inability to engage in lifestyle
modification, health beliefs, &
medication side effects),
physician-r/t (non-adherence to
treatment guidelines, failure to
emphasize lifestyle
modifications), health care
system r/t (lack of access to
care, high cost of medications).
Recommendations to overcome
these barriers should focus on
patient education, self –
monitoring with a home blood
pressure monitor, behavioral
counseling, and physicianrelated interventions.
MINT counseling led to steady
maintenance of medication
adherence over time, compared
to significant decline in
adherence for UC patients.
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Migneault, J. et al. (2012).
Annals of Behavioral Medicine,
43(1), 62-73.

337 participants from a large,
urban safety-net hospital and
community health centers.
Inclusion criteria were: (a)
African–American; (b)
diagnosis of hypertension on
the active problem list of the
patient’s medical chart; (c)
current prescription for ≥1
antihypertensive medications;
(d) ≥1 primary care office visits
in the previous 2 months; (e)
two elevated clinic BP readings
in the previous 6 months
(systolic blood pressure ≥140
mmHg and/or diastolic blood
pressure ≥90 mmHg among
non- diabetic patients, and
≥130/80 among diabetic
patients); and (f) age ≥35 years.

Randomized 337 patients to an
8-month automated, multibehavior intervention or to an
education-only control.
Medication adherence, diet,
physical activity, and BP were
assessed at baseline and every 4
months for 1 year. Data were
analyzed using longitudinal
modeling.

Automated telecommunications
systems can promote selfmanagement of diet and energy
balance in urban African–
Americans.
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Table 5: Nurse-Based Interventions
Author and Journal
Artinian, N., Washington, O.,
& Templin, T. (2001). Heart
and Lung

Sample
26 participants—3 (11.5%)
men and 23 (88.5%) women—
had a mean age of 59 years,
with a range of 32 to 93 years.
All participants were African
American.

Method
Pilot study with randomized
controlled design. Participants
were assigned to 3 groups:
home tele-monitoring plus
usual care; community-based
monitoring plus usual care; or
usual care only. Stratification
by use or nonuse of antihypertension medication was
used.

Findings
Participants in the home telemonitoring and communitybased monitoring groups had
clinically and statistically
significant reductions in both
SBP and DBP during a 3month monitoring period
compared with the participants
in the usual care group.

Bosworth, H. et al., (2009).
Annals of Internal Medicine,
151 (10), 687-w224.

636 Hypertensive patients

Randomized patients received
usual care, a behavioral
intervention (bimonthly
tailored, nurse-administered
telephone intervention targeting
hypertension-related
behaviors), home BP
monitoring 3 times weekly, or
the behavioral intervention plus
home BP monitoring.

Combined home BP monitoring
and tailored behavioral
telephone intervention
improved BP control, systolic
BP, and diastolic BP at 24
months relative to usual care.
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Table 6: Pharmacy-Based Interventions

Hunt, J. et al., (2008). Journal
of General Internal Medicine,
23(12), 1966-1972.

Ramanath, B., Nagakishore, C.,
& Kumar, M. (2012). Archives
of Pharmacy

In the Providence Primary Care
Research Network of patients
with hypertension and
uncontrolled blood pressure.

Pharmacy practitioners
participated in the active
management of hypertension in
the primary care office
according to established
collaborative treatment
protocols. Outcome measures
were the differences in mean
systolic and diastolic blood
pressures between arms at
study end and blood pressure
goal attainment (< 140/90
mmHg), hypertension-related
knowledge, medication
adherence, home blood
pressure monitoring, resource
utilization, quality of life, and
satisfaction.
Fifty-six patients were enrolled; Prospective, randomized
only 52 patients completed the interventional study.
Interventional group patients
study. Race was not specified.
received patient counseling,
patient information leaflets
(PILS), and frequent telephone
reminders. Medication
adherence and QOL were
assessed with the Morisky
Medication Adherence Scale

Patients achieved significantly
better blood pressure control
compared to usual care with no
difference in quality of life or
satisfaction.

Clinical pharmacist patient
counseling had a positive
impact on medication
adherence and QOL.
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(MMAS) and Medication
Adherence Report Scale
(MARS) Questionnaires and
SF-12v2 Quality of life
Questionnaire.
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Clinical Practice Model: Integrative Model of Behavior Change
Laneita Davis, FNP-BC, DNP-candidate
Belmont University
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One of the most prevalent and serious health issues among African-American patients is
hypertension. Though a large percentage of the population has hypertension, many do not follow
prescribed treatments or take medication for the condition. Statistics show that individuals of
African-American descent are more likely to develop hypertension than any other ethnicity in the
United States with about 43 percent of African-American men and 45 percent of AfricanAmerican women affected by the condition (Center for Disease Control [CDC], 2012). In
comparison, a national average of those suffering with this condition is 34 percent of men and 32
percent of women (CDC, 2012). Clearly, African Americans have a higher prevalence of this
serious illness. When left untreated, hypertension may result in life-threatening complication
including abdominal aortic aneurysm, chronic kidney disease, cardiac arrest, stroke, loss of
vision, or peripheral artery disease (CDC, 2012). However, despite the grave potential
consequences of leaving hypertension untreated, only seven out of ten Americans with the
condition use medication to control their high blood pressure (CDC, 2012). The Integrative
Model of Behavioral Prediction uses a reasoned action approach to understand behavior. The
model purports that although an infinite number of variables may in some way influence
behavior, only a small number of variables need to be considered to predict, change, or reinforce
a particular behavior in a particular population (Fishbein & Ajzen, 2010). This paper proposes an
intervention based on the Integrative Model of Behavioral Prediction, also known as I-Change
model. The I-Change model is a method used in modifying behavior that is easy to implement
and effective in changing behavior. The proposed intervention employs the I-Change Model as a
framework for persuading patients to take their hypertension medication as prescribed.
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Theoretical Framework
The Integrative Model of Behavior Change (I-Change Model) is the most recent
formulation of Fishbein and Ajzen’s (2010) reasoned action approach. The development of the
reasoned action approach has been sequential. Early work by Martin Fishbein in the 1960s
focused on conceptual differences between beliefs, attitude, and intention constructs in response
to scholars who doubted the usefulness of the attitude construct for predicting human behavior
(Fishbein & Ajzen, 2010). This early work informed the theory of reasoned action, which models
beliefs about particular outcomes and referents’ approval regarding the behavior as antecedents,
and intentions and behaviors as consequences of attitude (Fishbein & Ajzen, 2010). In the 1980s,
Icek Ajzen proposed the theory of planned behavior, which models perceived control over
behavioral performance as an additional behavioral determinant next to attitude and subjective
norm (Fishbein & Ajzen, 2010).
The work of Fishbein and Ajzen resulted in another formulation of the theory which was
proposed in 2000 as the Integrative Model of behavioral prediction (I-Change Model). The
newest formulation extends the scope of the normative determinant and point’s attention to skills
and environmental barriers as moderators of the intention–behavior relationship (Fishbein &
Ajzen, 2010). The I-Change Model assumes that the behavioral change process can be
segmented into three phases: 1) Awareness, 2) Motivation, and 3) Behavior. The model describes
a linear process toward behavior change. In the awareness phase, the participant becomes aware
of their risk behavior. As the individual becomes aware of the personal consequences of their
risky behavior, s/he may spend a significant amount of time thinking about the consequences of
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the risky behavior. When awareness is created, understanding takes place. This understanding
may help to change the individual’s attitude by developing a sense of responsibility for his/her
behavior. The sense of responsibility can mature into a motivation to change the risky behavior.
Important factors required to proceed through this phase, according to I- Change model, are
knowledge, risk perceptions, and cues that prompt awareness (Broekhuizen, Van Poppel,
Koppes, Brug, & Mechelen, 2010). In the motivation phase, a person becomes motivated to
change his/her risky behavior. Important factors influencing motivation are attitudes, social
support and self-efficacy expectations. Proceeding through the motivational phase results in
positive intention to change one’s behavior. Intention to perform a behavior is a function of
attitudes toward engaging in the behavior and perceived pressures to perform the behavior. In the
final phase, motivation and intentions transition to changed behavior. For behavior change and
maintenance, an individual attempts to convert his/her more global goal intentions into specific
implementation intentions or action plans, with relevant strategies that will enable him/her to
attain the desired goal of decreased risk (Broekhuizen et al. 2010). (See Figure 1).
Literature Support
In the past, the I-Change model has proven to be effective in dealing with a variety of
issues around the world. For example, in a skin cancer study conducted in Belgium, the I-Change
model was used to facilitate behavior changes related to the usage of sunscreen lotion among
teenagers (De Vries, Mesters, Riet, Willems & Reubsaet, 2006). De Vries and colleagues (2006)
reported that the regular usage of sunscreen was found in individuals who became aware of the
need to protect themselves from ultraviolet rays. The teens were motivated to be more careful
while outdoors, and took the necessary precautions to make certain they were protected by using
sunscreen and staying in the shade as much as possible. The I-Change Model was helpful in
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explaining the motivations and intentions of the individuals who were using sunscreen lotion in
determining behavior change. This study’s results were beneficial in the development of
programs that focused on skin cancer prevention and sunscreen promotion.
Another example of the I-Change Model use is described in the 2005 study of De Vries
and colleagues. The I-Change Model was used to analyze the general public’s need and
perceptions concerning information on the role of hereditary factors on cancer development. The
results from the study in 457 Dutch adults showed that 25% correctly indicated the types of
cancer in which hereditary factors played a role (De Vries, Mesters, Steeg, & Honing, 2005).
Using the I-Change Model was beneficial in determining the misconceptions regarding the
importance of genetics and its influence on certain types of cancers. De Vries and colleagues
(2005) analyzed levels of knowledge and interest regarding genetic information on hereditary
cancer. Based on the analysis, the group recommended a program to increase awareness and
recognition of potential hereditary predisposition in individuals. The study also found that
carefully planned information activities were needed to increase general knowledge about cancer
and cancer symptoms, and to establish correct perceptions of the types of cancer that have
hereditary components and personal risks.
The behavior change components of the I-Change model were a significant part of the
process of abusive alcohol consumption when studied by a Dutch survey of frequent drinkers
(Schulz, Kremers, & DeVries, 2012). The study found that for an individual who is attempting to
discontinue drinking or consume less alcohol, the first and most important factor to consider was
a change in his/her attitude towards drinking. Once the individual was made aware of his/her
risky behavior and the consequences, the individual became motivated to change the risky
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behavior. The support of the people around him/her is a strong and positive factor in moving to
the final step of behavior change. The final step of behavior change occurred when the drinker
was motivated to the point of action, at which point the individual reported some form of success
in achieving his/her goal (Schulz, Kremers, & DeVries, 2012).
The advantages of using this model are quite easy to see. The I-Change model can be
used to correct almost any behavior in an individual with need. It is applicable to modifying
behaviors related to smoking cessation, weight loss, or medication adherence. This model, unlike
many others, can cross over socioeconomic, geographic or ethical barriers with ease. The only
requirement is that an individual have a behavior s/he wants to change or modify. The
individual’s background, occupation or home situation is irrelevant because the I-Change model
is rooted in universal human nature. The only limitation to the I-Change model is an individual’s
willingness and determination to change. Because an individual’s awareness or motivation is
variable, some individuals may stall in a particular stage without progressing to the next stage in
the I-Change Model.
Gaps
The I-Change model is versatile in its usage and easy to implement in most settings,
including healthcare environments such as inpatient settings, outpatient clinics, community based
settings, or home healthcare visits. The model is viable when used in a large hospital as well as
in a free clinic that provides care to working class people without insurance. Since the I-Change
model is simple, straightforward and easy-to-comprehend, it can be used in any facility, any city,
and any country in the world with high success. Although the I-Change model has been used in a
variety of settings, it use has not been publicized in African Americans or rural settings.
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The quality and amount of healthcare that minority Americans receive is less than the
recommendations. Minorities are less likely to receive preventative healthcare, are more likely to
develop conditions such as heart disease or diabetes, and are less likely to have a healthcare
provider who is familiar with their situation and whom they visit on a regular basis for check-ups
(Graham, 2011). These minority individuals are less likely to receive health-screenings or to
have easily available and affordable healthcare. Among African-Americans, for example, close
to half of the population has hypertension (CDC, 2012). A large number of African Americans
do not have access to regular healthcare and, therefore, may believe that medicine or visits to a
healthcare provider are unimportant until severe complications develop (Artinian, Washington,
& Templin, 2001). Educating African Americans about the risks of high blood pressure and
teaching them how to monitor their blood pressure at home will result in more people realizing
that high blood pressure is a serious, important health factor that should not be overlooked.
According to the I-Change Model, being aware of a risky behavior could move an individual
toward motivation to attend to the serious condition of hypertension. This motivation could make
more patients attempt to adhere to their blood pressure medication regimen as a behavior change.
The I-Change Model is a framework that could influence African Americans to take greater care
to lower their blood pressure. Using the I-Change model would be easy and efficient and have a
positive impact on the health and well-being of African-Americans and other minority groups.
The Integrated Theory of Health Behavior Change suggests that health behavior change can be
enhanced by fostering knowledge and beliefs, increasing self-regulation skills and abilities, and
enhancing motivation.
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Application

In the case of implementing the I-Change model to treat hypertension among AfricanAmerican patients, there are no modifications that need to be made in the basic model. The
intervention is done in three parts: awareness, motivation and behavior. In the awareness step of
this project, the patients would receive instruction on the health risks of untreated hypertension
and the potential complications. The patients would also be taught how to easily monitor his/her
blood pressure at home. By performing home blood pressure monitoring, an individual would
have an increased awareness by increasing his/her risk perception with visual cues to trigger a
need for behavior change. The motivation step of the project would involve the individual
applying the new knowledge, performing home blood pressure monitoring, and keeping a record
of his/her blood pressure results. Seeing his/her blood pressure results and knowing the potential
outcome of leaving high blood pressure untreated are cues about the individual’s risk. Hopefully,
this knowledge would lead the individual to transition to the third stage of the I-Change model’s
process, which is behavior. It is in this final step that the patient applies his/her motivation and is
spurred into action for behavior change. The individual engages actively to do his/her best to
lower his/her blood pressure by adhering to the prescribed medical regimen. The determination
to change their behavior is built on the model’s components of awareness and motivation. The
intervention will have run its course when the patient engages in behavior that is compliant with
his/her prescribed medical regimen.
The biggest barrier to achieving the desired behavior is the chance that the patient
becomes stalled at one stage of the process before the behavior change occurs. This stall risk is
most likely to occur in the beginning of the process, when the patient may not have enough
interest or social support to move on to the second stage. In the motivational stage, the patient
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might experience waning motivation, which could delay progress to the final behavior change. If
a person is not ready to change, then the change will not occur. People develop motivation and
readiness at different rates; some will need time before they are ready to actively make a change
in their behavior.
Healthcare providers need to be aware that the I-Change model is a three-stage process.
A patient must proceed from one stage to the next in a predetermined order before s/he can
succeed in changed behavior. Motivation cannot come before awareness, since it is difficult to
become motivated to change something if one is not aware it is an issue. It must be noted that the
patient is likely to move back and forth between the stages based on his/her emotional outlook at
any given point in time. The patient’s determination and desire to make a change are of great
importance in achieving success. Therefore, it is entirely likely that a patient may move between
stage one and two or two and three several times before a permanent behavior change takes
place. Healthcare providers should recognize this movement between stages as commonplace.
Conclusion
Though non-adherence to hypertension treatment is a serious problem with AfricanAmerican patients, the I-Change model of intervention would be an efficient model to help
patients to comply with their prescribed medical regimen. Through education about their
condition, potential complications that could arise due to non-compliance with prescribed
treatments, and information on how to monitor their blood pressure at home, the patient will be
motivated to make a behavior change. Because the I-Change model is effective, simple to follow,
and adaptable to any environment, it is an ideal model choice in behavior modification. The IChange model can help many patients change their health behavior. Implementing this model
would create a positive change in African Americans with hypertension in a rural setting.
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Engagement in healthy behavior is essential to improvement of health and management
of chronic conditions. Nurses and other healthcare providers benefit from knowing how to
support the initiation and maintenance of health behavior change by individuals. The I-Change
model presented is an integration of past successes and makes substantive contributions to
understanding health behavior change by combining knowledge and beliefs, and self-regulation
processes. It is purported that the behavior changes necessary to manage chronic conditions are
more similar than different than behavior changes necessary for health promotion. Measurement
of behavior change occurs proximally to ensure that behavior change has actually occurred, as
well as distally to ensure attainment of improved health status.
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High blood pressure is a major risk factor for heart disease and stroke, both of which are
leading causes of death in the United States. Nearly one-third of all American adults have high
blood pressure and more than half of those affected do not have well-controlled hypertension
(Center for Disease Control [CDC], 2013). Hypertension is 30%–50% more prevalent in African
Americans than Caucasians and accounts for half of the excess cardiovascular mortality observed
in African Americans (Bravermen & Dieder, 2009). Of those diagnosed with hypertension,
African Americans have lower rates of blood pressure (BP) control than other ethnicities, and
this disparity has increased over time (Bravermen & Dieder, 2009). Poor medication adherence
to prescribed antihypertensive medications contributes significantly to lower BP control and
increasing such adherence is considered to have the greatest potential to improve BP control
(CDC, 2013). According to a 2003 report by the World Health Organization, approximately 50%
of patients do not adhere to their medications as prescribed (Brown & Bussell, 2011). Adherence
is a key factor associated with the effectiveness of all pharmacological therapies but is
particularly critical for medications prescribed for chronic conditions. Of all medication-related
hospitalizations that occur in the United States, between one-third and two-thirds of the
admissions are the result of poor medication adherence (CDC, 2013). Home blood pressure
monitoring is one strategy that can be implemented in the African American community to
improve medication adherence in an effort to reduce morbidity and mortality related to
hypertension. Home blood pressure monitoring is defined as the regular measurement of blood
pressure by the patient outside the clinical setting, either at home or elsewhere (Bravermen &
Dieder, 2009). The purpose of this project, is to evaluate the effectiveness of home blood
pressure monitoring on medication adherence and blood pressure control in African Americans.

MEDICATION ADHERENCE

55

Theoretical Framework
The theoretical framework for this project is based on the I-Change model. The I-Change
model is loosely founded on the Attitude-Social Influence-Self efficacy (ASE) model
(Broekhuizen, van Poppel, Koppes, Brug & Mechelen, 2010). The I-Change model consists of
three components; Awareness, Motivation, and Action. In the initial Awareness step, the patient
is made aware not only of the risk of unmanaged hypertension [HTN], but also of the need for
changing his/her behavior. In this scholarly project, the initial step was accomplished by sharing
information with the patient about the risks involved in ignoring their hypertension, as well as
the benefits of improved HTN control. Because patients recall as little as 50% of what is
discussed during the typical medical encounter, effective patient education must be
multifactorial, and individualized (Brown & Bussell, 2011). A key component of any adherenceimproving plan is patient education. This knowledge could provide awareness for his/her need of
a change. Following the Awareness step of the I-Change model is Motivation. In the Motivation
step, an individual became motivated to improve his/her health habits. In this scholarly project,
Motivation was accomplished through teaching the patients to self-monitor their blood pressure
at home. When an individual saw the actual blood pressure numbers and related the BP values to
information related to HTN risks, she/he was motivated to change their current habits in order to
reduce risks and improve benefits. Proceeding through the motivational step of the I-Change
model resulted in the patient developing positive intentions to change his/her current behavior.
The final step of the I-Change process after Awareness and Motivation is the Action step. In the
Action step of the scholarly project, the patient followed the natural course of Awareness and
Motivation and took Action to improve his/her medication adherence to reduce risk and improve
benefit of managed HTN. In this project, the patient took action by following his/her prescribed

MEDICATION ADHERENCE

56

medication regimen. In order to create Motivation, individuals were taught how to use a home
blood pressure monitor. The individual was motivated by seeing and recording his/her daily
blood pressure values. Seeing his/her blood pressure values combined with Awareness of the
risks of uncontrolled HTN and the benefits of managed HTN, facilitated the individual Action of
taking antihypertensive medications as prescribed.

Design
This project was a feasibility pilot study, which used a randomized control design.
Participants were randomly assigned to one of two groups. Group A, received the intervention of
home-monitoring plus education, and Group B, received usual care (clinic monitoring).
Randomization assignments were determined before the start of data collection by using an
online randomization tool. Approval by the Belmont University Institutional Review Board was
obtained prior to implementation of the study.

Setting/Sample
This scholarly project was conducted in Tunica County Mississippi at the Preventative
Health Clinic, one of two clinics serving the area. Preventive Health Clinic provides health
services to more than 1000 adults and children, 90% of whom are African American.
Approximately 50% of the clinic’s patients have HTN and are prescribed medications to control
and manage the chronic disease. The majority of Tunica County residents are African American
(76%) and many are below the poverty level according to the most recent US Census
information (2013). The Tunica County residents reflect the state of health in Mississippi in
which not only more than 700,000 adults have HTN, but also in which cardiovascular disease is
the highest in the nation.
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Recruitment
Recruitment for potential participants was conducted between June 1, 2013 and
September 30, 2013. Recruitment posters were posted throughout Tunica County at businesses
(Exxon gas station, Piggly Wiggly grocery store, and the Fred’s convenience store), flyers were
placed in church bulletins (the Macedonia, St. Luke, Belmont, and Love Temple Baptist
churches) and advertisements were published in the local newspaper (Tunica Times). Inclusion
criteria for participants were: 1)African American patients diagnosed with hypertension and
prescribed anti-hypertensive medication, 2) >18 years of age, 3)English speaking, and 4)nonadherent to their medications as evidenced by self- report and by the Morisky 8-Item Medication
Adherence Questionnaire. Exclusion criteria: 1) physical, mental and health restrictions, 2)
unable to duplicate self-monitoring demonstration, 3) less than 18 years of age, and 4)
participants not meeting inclusion criteria. Participants were asked to contact the investigator via
telephone or email if interested in participating in the study.
During the recruitment phase, potential participants contacted the principal investigator
(PI) via email or phone if he/she was interested in the study. During the initial phone call, a
mutually agreeable upon date and time was set to meet with the participant at Preventative Care
Health Services clinic. The potential participant completed the Morisky 8-Item Medication
Adherence Questionnaire and a demographic survey. If the participant scored greater than a 2 on
the Morisky Questionnaire, and met all other inclusion criteria, this person was eligible to
participate in this project. After determining eligibility, the principal investigator obtained an
informed consent and baseline blood pressure readings.
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Data Collection
Eligible participants were randomized into two groups; the home blood pressure
monitoring group (intervention group n=10) or the usual care group (clinic monitoring n=10). An
online randomization tool was utilized to determine group orientation. At the first meeting,
participants in the intervention group were given a brief overview of hypertension, which
included: signs and symptoms, the staging of hypertension based on the JNC-VII guidelines, and
the meaning of systolic and diastolic blood pressure values. All provided education materials
were located in the manufacture’s home BP monitor instruction manual. After the education
session was completed, the principal investigator measured the participant’s arm and selected the
appropriate blood pressure cuff. The participants were instructed on the proper technique of
taking an accurate blood pressure and given an education pamphlet to reinforce learning (See
Appendix A). To validate understanding, each participant performed a return demonstration. The
blood pressure machine used for this project was the Omron 7 series model BP760. To ensure
reliability, the machine was validated and approved by the Association for the Advancement of
Medical Instrumentation, the British Hypertension Society and the International Protocol for the
Validation of Automated BP Measuring Devices. The principal investigator calibrated the blood
pressure machine. The participants were asked to take his/her blood pressure twice a day, one
reading in the morning and one in the evening for 12 weeks, and record his/her readings in the
provided journals. The usual care group had their blood pressure taken during the study time
according to the recommendations of his/her PCP. At the end of the 12-week period, the usual
care and the intervention group participants returned to the clinic to complete the postintervention Morisky questionnaire, and have their blood pressure taken and recorded by the
principal investigator. The primary project objective was to demonstrate increased medication
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adherence after 12 weeks of home self-monitoring blood pressure with a decreased Morisky
score. The secondary project objective was to have an improvement in blood pressure values as
evidenced by a drop in systolic and diastolic blood pressure values after 12 weeks.

Data Analysis
Data analysis procedures were conducted by using SPSS statistical software. Descriptive
statistics were used to analyze all study variables. Fisher’s exact was used to measure medication
adherence and blood pressure control between groups. Blood pressure was analyzed as the
dichotomous variable (“uncontrolled” or “controlled”) according to the JNC-VII national
guidelines (Chobanian, Bakris, Black, Cushman, Green, Izzo, et. al., 2008). Specifically, among
non-diabetic participants systolic blood pressure (SBP) values ≥140 mmHg and diastolic blood
pressure (DBP) values ≥90 mmHg were considered “high”. The corresponding BP cut-off for
diabetic participants was 130/80 mmHg.
Self-reported medication adherence was measured with the eight-item Morisky
Medication Adherence Scale (MMAS) (Morisky, Krousel-Wood, & Ward, 2008). This
adherence measure was designed to facilitate the identification of barriers to and behaviors
associated with adequate adherence to chronic medications. In previous studies, the scale has
been reliable (α= 0.83) and associated with significant blood pressure control (p<0.05) in low
income, mostly minority and underserved individuals with hypertension. Also, the MMAS has
demonstrated high concordance with antihypertensive medication pharmacy fill rates. MMAS
scores range from 0 to 8 with low adherence defined as >2; medium adherence as 1 to 2, and
high adherence as 0 (Morisky, Krousel-Wood, & Ward, 2008). For this scholarly project, the
MMAS score was summed and dichotomized into 2 categories. Non- adherence was any score
greater than two, and adherence was any score less than or equal to two. (see Appendix B).
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Results
Of 20 patients included in the study, 45% were between the ages of 31-40, 60% were
women, 40% had graduated from high school, and the mean number of antihypertensive
medications being taken was 1.5 (range, 1-4 medications). Complete demographic
characteristics of the study participants are listed in Table 1. The mean (SD) MMAS score was
7.4 (0.9). A chi-square 2x2 was performed to find a significant difference between those in the
intervention group and increased medication adherence. However, since the predicted cell size
for two of the cells was 4, the chi-square test was not appropriate to calculate the p value.
Because the predicted cell size was less than 5, the Fisher’s exact test was appropriate to
calculate the p-value (See Table 5). The Fisher’s exact test found a significant difference for
medication adherence between the home monitoring group and the usual care group, p<.05.
Seventy percent of patients in the home monitoring group had an improved medication
adherence score compared to only 10% in the control group post intervention. After blood
pressure was dichotomized, a chi-square test was used to determine whether there was a
significant difference in blood pressure control between participants who performed home blood
pressure monitoring and those who did not. There was not a significant difference found between
the intervention group and control group with p >.05.
Discussion
The purpose of this project was to test the effectiveness of home blood pressure
monitoring on medication adherence and blood pressure control in African Americans with
HTN. Despite the small sample size, results indicate that the participants in the intervention
group had a statistically significant difference in their medication adherence scores after the
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intervention than those in the control group. Although there was a lower reduction in both
systolic and diastolic blood pressures in the intervention group compared to the control group,
these results were not statistically significant (figure 1 & 2). Participants in both groups had
blood pressures values that were normal post intervention. This result may have been related to
the participants in the control group using other methods for improving BP such has exercise or
other lifestyle modifications. Of the twenty participants, only three had an uncontrolled blood
pressure post intervention, two were in the control group and one in the intervention group. This
result may have been related to the anxiety of being in the study.
.

These are important pilot results, which, if replicated in a larger sample, could

significantly improve care and health outcomes for African Americans with hypertension in a
rural setting. Home blood pressure monitoring allows the patient to gain an increased interest in
the management of their hypertension and to provide the patient with self-confidence and
feelings of reassurance. The tangible blood pressure readings from home blood pressure
monitors turned this largely asymptomatic disease into a condition that is measurable in the
patients' own homes. Seeing and recording the blood pressure readings could be the patient’s
motivation facilitating the Action of adhering to his/her prescribed medication regimen.
Although there may be advantages to home BP monitoring, more research is needed to determine
the effects of this strategy on long-term control of hypertension.
Limitations
Some of the limitations of this study include external validity, or the generalizability of
the study. There were only 20 participants who participated in the complete study, and all but
one of the participants were high school graduate or beyond. In addition, the participants were all
middle to upper middle class adults. In future studies, more research is needed to view
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medication adherence in individuals with low socioeconomic status. Tunica, MS is a small rural
community and the principal investigator is well known. Many of the participants knew the PI,
and this could have caused a false positive result related to the participants wanting to perform
well because they knew the principal investigator. In this project, the PI purchased individual
blood pressure cuffs. Some individuals that are at or below poverty level may not have the
additional funds to purchase a personal blood pressure monitor therefore, future studies are
needed on the effectiveness of public kiosk monitoring on medication adherence and blood
pressure control. There was a small amount of education performed at the beginning of the
project based on information from the pamphlet in the blood pressure machine. This may have
not been enough information to create awareness to promote a true behavior change that could be
sustained. In future studies, additional educational information is needed in the form of a video
or handouts to ensure that the participants understand the information. In addition to this added
education, more qualitative information is needed on the participants feelings and their response
to home blood pressure monitoring and medication adherence.
Implication for Nurses
Nurses play a pivotal role in helping patients to adhere to their medication and increasing
blood pressure control. Nursing leadership is important in helping the community understand the
importance of taking control of their health. One strategy is through self blood pressure
monitoring. For this study, blood pressure monitors were purchased for the participants use, but
consideration must be given to individuals who can not afford to purchase a home blood pressure
monitor. Self- service kiosks are designed to help consumers monitor and improve their actual
health. These health-related kiosks allow users to conveniently monitor their condition, set
personal health goals, and measure and track their results. In most cities throughout the United
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States, kiosks are usually located at the local grocery stores or pharmacy and can be used at the
customer’s convenience. In the small town of Tunica, MS., there are currently no blood pressure
kiosks located in any of the grocery stores or pharmacies. Since Tunica has only two health
clinics that service about 8,000-10,000 people, scheduling an appointment is often difficult.
Although the prices of the blood pressure kiosks are expensive, research has shown that
the long-term benefits of a public kiosk are beneficial. Atkins (1996) found that public kiosks
had a profound effect on pharmacy revenue. Stores that had a blood pressure kiosk increased
pharmacy revenue by more than fifty percent. Atkins (1996) also found that grocery stores with a
kiosk had increased sales and revenue. Research shows that consumers enjoy the convenience of
self‐service and are more likely to do business with companies that offer the convenient service.
A cost- effective study performed by the principal investigator examined the cost of clinic
monitoring versus kiosk monitoring and found that the total cost would be $16.44/person at the
clinic and $.40/person at the kiosk (See figure 3).
It was important to advocate and share with key stakeholders the importance of
purchasing a blood pressure kiosk for the people of Tunica, MS. The PI had a meeting
scheduled with Rev. McKinnely Daley, a representative on the Tunica County Board of
Supervisors to discuss obtaining a public blood pressure kiosk for the residents of Tunica, MS.
Before the scheduled meeting, a vandalism event occurred at the local high school incurring
more than one hundred thousand dollars in damages. In Tunica County, this was not only a
significant expenditure, but also a major disruption in the community. Therefore, the meeting
between the PI and the County Supervisor was postponed, and is currently pending. Nurses
should seek opportunities to advocate for the patient and the community. Advocacy and
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leadership are appropriate roles for nurses that can positively impact individuals’ and
communities’ health. Nurses can assess communities’ needs and find cost effective solutions
similar to the described home blood pressure monitoring project.
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TABLE 1
Characteristics of Participants
(n=20)
Characteristics
Age

N(%)
31-40
41-50
Over 51

9(45)
6(30)
5(25)

Female
Male

12(60)
8(40)

Completed HS
Some College
College
Graduate

8(40)
4(20)
7(35)
1(5)

Fulltime
Part-time
Unemployed

18(90)
1(5)
1(5)

<$200/week
$200-$499/week
$500-$799/week
$800-$1000/week
>$1000/week

1(5)
6(30)
7(35)
5(25)
1(5)

Gender
Education

Employment

Income

Table 2: Hypertension Characteristics
Mean (S.D.)
Number of Meds
1.5 (.76)
Years with HTN
2.4(.99)

Range
1-4
1-4
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Table 3: Pre/Post BP Values
Mean (S.D.)

Range

Systolic BP
Pre-intervention
Post-intervention

139.35 (17.30)
134.25 (10.77)

122-200
118-160

Diastolic BP
Pre-intervention
Post-intervention

83.95(15.05)
76.20(6.70)

62-125
68-88

Mean (S.D.)

Range

5.45 (1.31)
3.95(1.87)

3-7
1-7

Table 4: Pre/Post Morisky scores

Morisky Score
Pre-intervention
Post-intervention

Table 5: Chi-Square Test and Fisher’s Exact

Value

Chi-Square Tests
Asymp. Sig.
df
(2-sided)

Exact Sig. (2- Exact Sig. (1sided)
sided)

Pearson Chi7.500a
1
.006
Square
Continuity
5.208
1
.022
Correctionb
Likelihood Ratio
8.202
1
.004
Fisher's Exact
.020
.010
Test
Linear-by-Linear
7.125
1
.008
Association
N of Valid Cases
20
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is
4.00.
b. Computed only for a 2x2 table
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Appendix A: Educational Handout

The ABCD’s of Blood Pressure Measurement

Achieve a calm state




Make sure you are quiet and relaxed
Sit calmly without talking for about 5 minutes
Make sure your reading isn’t affected by:

caffeine, alcohol,

exercise
or smoking

Body posture is important
 Sit in a chair with feet on the floor
 Legs should not be crossed
 Arm should be bare and should be supported at heart level

Calibrate & check equipment
 Use a properly calibrated and validated instrument
 Check the cuff size and fit
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Double check any high readings
 If blood pressure registers high,take two readings 5 minutes
apart


Confirm any elevated readings in the opposite arm
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Appendix B: Morisky 8-item Medication Adherence Questionnaire

Morisky 8-Item Medication Adherence Questionnaire
Question

Patient Answer
(Yes/No)

Score Y=1;

Do you sometimes forget to take your medicine?
People sometimes miss taking their medicines for reasons other than forgetting. Thinking over the past 2 weeks, were there
any days when you did not take your medicine?
Have you ever cut back or stopped taking your medicine without telling your doctor because you felt worse when you took
it?
When you travel or leave home, do you sometimes forget to bring along your medicine?
Did you take all your medicines yesterday?
When you feel like your symptoms are under control, do you sometimes stop taking your medicine?
Taking medicine every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your
treatment plan?
How often do you have difficulty remembering to take all your medicine?
A = 0; B-E
__ A. Never/rarely __ B. Once in a while __ C. Sometimes __ D. Usually __ E. All the time
Total score
Scores: >2 = low adherence 1 or 2 = medium adherence 0 = high adherence
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
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Figure 3

Clinic Monitoring

Ambulatory Blood pressure
Monitoring ( kiosk)

Blood pressure machine
.40

Kiosk blood pressure
0.40

Transportation to clinic
$11.00

transportation to kiosk (at patient's
convience
0.00

completing paper work ($3.36 adm. fee)

no wait time (0.00)

nurse performing bloodpressure
($1.68 nurse wage)

no nurse wage
0.00

Results
Total Cost $16.44

Instant REsults
Total Cost 0.40
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Scholarly Project Conclusion

Hypertension in the African American population is a substantial problem that continues
to grow. Medication adherence is one effective method to controlling blood pressure in African
Americans. As discovered through the literature search, there have not been enough studies
evaluating improving medication adherence and blood pressure control in a rural setting. As a
result, there is minimal understanding of the population and its healthcare and other needs. It
must be emphasized that accurate measurement of blood pressure is of fundamental importance
in management of hypertension. Through this scholarly project, it was found that home blood
pressure monitoring led to an increase in medication adherence. Although there was not
significance in actual blood pressure control, this pilot study shows the need for further research
in this population.
The writing and research of this project gave me the opportunity to expand ways to help
the people of my community. The continuation of research in this area is critical in finding cost
effective ways to manage this asymptomatic disease. As a healthcare provider, it is important to
bridge the gap between the availability of effective interventions and successful control of
hypertension.

